Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOSAIC: Selonsertib in Diabetic Kidney Disease
NCT04026165Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Jul 2019
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of selonsertib in diabetic kidney disease (DKD), sponsored by Gilead Sciences. Started Jul 2019; status: completed.
02
Drugs
selonsertib
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT04026165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04026165.